Mood Management Versus Mood Tolerance in Alcohol Treatment04/01/2000 - 03/31/2004 (Co-PI)
NIH/National Institute on Alcohol Abuse and Alcoholism5 R03 AA12210 02
Clinical Research Sites for the NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder03/15/2021 - 03/14/2023 (PI)
National Institutes of Health/DHHS/NIH75N94021D00003-0-759402100001-1
The Effects of the Histamine-3 Receptor Inverse Agonist Pitolisant on Alcohol Self-Administration in Heavy Drinkers09/20/2020 - 08/30/2022 (PI)
National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS1R21AA028864-01
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers09/25/2018 - 08/31/2021 (PI)
NIH-NIAAA5R21AA027332-02
R21 - Lacosamide effects on alcohol self administration and craving in heavy drinkers09/20/2017 - 08/31/2021 (PI)
NIH-NIAAA5R21AA026389-02
Wearable Noninvasive Blood Alcohol Monitor08/01/2019 - 02/17/2020 (PI)
KWJ Engineering NIH-NIAAA
NCIG-7 Randomized, Double Blind, Placebo-Controlled Trial of the Efficacy of Intranasal Oxytocin…01/01/2018 - 05/24/2019 (PI)
Fast Track Drugs and Biologics NIH-NIAAA
Lorcaserin - Phase 2, Multi-Center Trial of Lorcaserin for the Treatment of Cocaine Use Disorder04/01/2017 - 04/30/2019 (PI)
NIH-NIDA
NCIG-006, Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of …04/01/2015 - 09/19/2017 (PI)
Fast Track Drugs and Biologics NIH-NIAAA